HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
4-[3-(Trifluoromethyl)phenyl]-4-piperidinol → 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 4-[3-(Trifluoromethyl)phenyl]-4-piperidinol | HCID 75255 | — |
| Edukt | Diisopropylethylamine | HCID 81531 | — |
| Edukt | 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chloride | HCID 86672020 | — |
| Lösungsmittel | Dichloromethane | HCID 6344 | — |
| Lösungsmittel | Ethyl Acetate | HCID 8857 | — |
| Produkt | 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol | HCID 69672299 | 100% |
Reaktionsschritte
A solution of 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chloride (example 2) (0.400 g, 1.38 mmol), 4-(3-(trifluoromethyl)phenyl)piperidin-4-ol (0.371 g, 1.51 mmol), and diisopropylethylamine (0.535 g, 4.14 mmol) in dichloromethane (3 mL) was stirred at room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate (50 mL), washed with 10% citric acid (20 mL) and brine (20 mL). The organic layer was dried over sodium sulfate. Filtration and concentration afforded 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol (0.688 g, 100%) as a white solid that was used without further purification. MS (EI) for C22H22BrF3N2O3: 500 (MH+).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08637499B2 |
| Quelldatensatz | uspto-grants-2014_01 |
| ORD ID | ord-3e1f61430f1a49f780df481a54dbea9d |
| Quellennotiz | uspto-grants-2014_01 |